Difficulty: Medium
Average Score: 91%
Practice
A 5-year-old boy develops hepatosplenomegaly and lymphadenopathy since early onset childhood with high spiking fevers and been treated with anti-inflammatory drugs. You suspect macrophage activation syndrome (MAS). The BEST test that distinguishes MAS from a flare of the primary disease is
Correct answer
D
Rationale
In the case presented, the correct answer is D) hypertriglyceridemia.
Explanation:
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of various rheumatic diseases in children, characterized by excessive immune system activation and cytokine release. One of the key distinguishing features of MAS is the presence of hypertriglyceridemia, which is a result of the dysregulated immune response leading to abnormal lipid metabolism.
Why the other options are incorrect:
A) Leucopenia: While leucopenia can be seen in MAS, it is not a specific enough marker to definitively distinguish MAS from a flare of the primary disease as it can also occur in various inflammatory conditions.
B) ESR (erythrocyte sedimentation rate): ESR is a non-specific marker of inflammation and can be elevated in both MAS and a flare of the primary disease, making it less useful for differentiation.
C) Failing hypofibrinogenemia: Hypofibrinogenemia is a common finding in MAS, but it is not as specific or sensitive as hypertriglyceridemia in distinguishing MAS from a flare of the primary disease.
Educational context:
Understanding the clinical manifestations and diagnostic criteria for MAS is crucial for pediatric nurses caring for children with rheumatic diseases. Recognizing the key laboratory findings such as hypertriglyceridemia can aid in early identification and prompt management of MAS, which is essential for improving patient outcomes. Nurses play a vital role in monitoring and assessing these patients, making knowledge of MAS and its diagnostic markers essential in pediatric nursing practice.
Explanation:
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of various rheumatic diseases in children, characterized by excessive immune system activation and cytokine release. One of the key distinguishing features of MAS is the presence of hypertriglyceridemia, which is a result of the dysregulated immune response leading to abnormal lipid metabolism.
Why the other options are incorrect:
A) Leucopenia: While leucopenia can be seen in MAS, it is not a specific enough marker to definitively distinguish MAS from a flare of the primary disease as it can also occur in various inflammatory conditions.
B) ESR (erythrocyte sedimentation rate): ESR is a non-specific marker of inflammation and can be elevated in both MAS and a flare of the primary disease, making it less useful for differentiation.
C) Failing hypofibrinogenemia: Hypofibrinogenemia is a common finding in MAS, but it is not as specific or sensitive as hypertriglyceridemia in distinguishing MAS from a flare of the primary disease.
Educational context:
Understanding the clinical manifestations and diagnostic criteria for MAS is crucial for pediatric nurses caring for children with rheumatic diseases. Recognizing the key laboratory findings such as hypertriglyceridemia can aid in early identification and prompt management of MAS, which is essential for improving patient outcomes. Nurses play a vital role in monitoring and assessing these patients, making knowledge of MAS and its diagnostic markers essential in pediatric nursing practice.